Side-by-side comparison of AI visibility scores, market position, and capabilities
Compliance management platform for financial services, NYC. Covers personal trading, conflicts of interest, and regulatory reporting for investment advisers and broker-dealers.
ComplySci is a New York City-based regulatory compliance technology company that provides a compliance management platform specifically designed for registered investment advisers (RIAs), broker-dealers, hedge funds, and other financial services firms. The company's platform helps compliance officers manage personal trading surveillance, employee disclosures, conflicts of interest monitoring, licensing and registration tracking, and regulatory filing workflows — the core obligations of a securities compliance program under SEC and FINRA regulations.\n\nComplySci's personal trading compliance module automates pre-clearance requests and holds, monitors employee brokerage accounts for potential conflicts, and generates the audit trails required for SEC examinations. The platform's disclosure management capabilities streamline annual questionnaires and ongoing material change disclosures for registered representatives, reducing manual follow-up and paper-based workflows that create compliance risk in large organizations. ComplySci serves hundreds of investment management firms ranging from boutique RIAs to large asset managers.\n\nThe company competes with Star Compliance, Actimize, and MCO (My Compliance Office) in the investment management compliance platform market. ComplySci differentiates through deep domain expertise in securities regulatory requirements and strong customer service, positioning itself as a specialist alternative to broader GRC platforms that lack financial services-specific functionality. The company has expanded its product through strategic acquisitions and partnerships with compliance consulting firms to offer a more complete compliance program management solution.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.